The conversion of fatty acids to fatty alcohols is required for the synthesis of wax monoesters and ether lipids. The mammalian enzymes that synthesize fatty alcohols have not been identified. Here, an in silico approach was used to discern two putative reductase enzymes designated FAR1 and FAR2. Expression studies in intact cells showed that FAR1 and FAR2 cDNAs encoded isozymes that reduced fatty acids to fatty alcohols. Fatty acyl-CoA esters were the substrate of FAR1 and the enzyme required NADPH as a cofactor. FAR1 preferred saturated and unsaturated fatty acids of 16 or 18 carbons as substrates whereas FAR2 preferred saturated fatty acids of 16 or 18 carbons.
INTRODUCTION
Wax esters are abundant neutral lipids that coat the surfaces of plants, insects, and mammals. They are composed of long chain alcohols esterified to fatty acids and have the chemical property of being solid at room temperature and liquid at higher temperatures. Waxes play essential biological roles in preventing water loss, abrasion, and infection, and are produced commercially at levels approaching 3 billion pounds per year for use in polishes, cosmetics, and packaging. In some mammals, wax esters constitute ~30% of sebum and meibum, the oils secreted by the sebaceous and meibomian glands onto the surfaces of the skin and eye, respectively (1,2).
Although the enzymes of wax biosynthesis in mammals have not been isolated, the components of the pathway can be inferred from work in plants (3, 4) and mammalian tissue extracts (5) . As indicated in Scheme 1, two catalytic steps are required to produce a wax monoester, including reduction of a fatty acid to a fatty alcohol and subsequently, the trans-esterification of the fatty alcohol to a fatty acid. The first step is catalyzed by the enzyme fatty acyl-CoA reductase, which uses the reducing equivalents of NAD(P)H to convert a fatty acyl-CoA into a fatty alcohol and CoASH. cDNAs specifying fatty acyl-CoA reductases have been identified in the jojoba plant (6) , the silkworm moth (7), wheat (8) , and in a microorganism (9) ; however, the biochemical properties and subcellular localizations of these enzymes have not been reported.
Fatty alcohols have two metabolic fates in mammals; incorporation into ether lipids or incorporation into waxes. Ether lipids account for ~20% of phospholipids in the human body and are synthesized in membranes by a pathway involving at least seven 3 enzymes (10) . The second step of this pathway is catalyzed by the enzyme alkyldihydroxyacetone phosphate synthase, which exchanges an sn-1 fatty acid in ester linkage to dihydroxyacetone phosphate with a long chain fatty alcohol to form an alkyl ether intermediate. Once produced, ether lipids are precursors for platelet activating factor, for cannabinoid receptor ligands, and for essential membrane components in cells of the reproductive and nervous systems (10, 11 ).
In the current study a bioinformatics approach was used to identify mouse and human cDNAs encoding two fatty acyl-CoA reductase isozymes designated FAR1 and FAR2 . The biochemical properties and subcellular localizations of recombinant FAR enzymes expressed in cultured mammalian and insect cells were defined, and tissue distributions were delineated. An accompanying study reports the isolation and characterization of a wax synthase enzyme that catalyzes the second step of the mammalian wax biosynthetic pathway (12) . 4 
EXPERIMENTAL PROCEDURES
Bioinformatics and cDNA Cloning -Fatty acyl-CoA reductase protein sequences from the jojoba plant (Simmondsia chinensis, (6) ) and the silkworm moth (Bombyx mori, (7) ) were compared to those in the protein database using the program BLASTP (13) to identify potential mouse and human reductase sequences.
Two proteins with approximately 30% sequence identity to the plant and insect enzymes were identified and cDNAs for each were obtained. A mouse fatty acyl-CoA reductase 1 cDNA (mFAR1, Following construction of the donor plasmids, infectious Autographica californica nuclear polyhedrosis baculovirus stocks were generated and titrated in Spodoptera frugiperda (Sf9) cells using the Bac-to-Bac Baculovirus Expression System kit (Invitrogen). 
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The amounts of FAR1 and FAR2 mRNAs were determined in different tissues of the mouse by real time PCR (Fig. 2) . The FAR1 mRNA had the broadest distribution, being present at readily detectable levels (C T = 16.8 to 28) in the twenty tissues or cell lines examined (Fig. 2, left In an effort to increase expression of FAR1 and FAR2, the mouse cDNAs were recombined into baculovirus expression vectors as described in "Experimental The FAR1 enzyme preferred C16, C18, C18:1, and C18:2 fatty acids, and was less active against other lipids (top panel). With longer exposures of the TLC plate to X-ray film, activity was observed when C10 -C14 substrates were added to the medium. All fatty acids tested were incorporated into lipids having the same mobility as monoacylglycerols by an endogenous insect activity and to a lesser extent into diacylglycerol products, indicating that they gained access to biosynthetic enzymes in the infected cells.
Experiments done with microsomal membranes from FAR1-expressing Sf9 cells produced similar results with respect to fatty acid substrate preference (data not shown).
In contrast to the substrate preference of the FAR1 enzyme, the FAR2 enzyme showed a more narrow specificity for fatty acids, acting with partiality towards saturated C16 and C18 lipids (Fig. 5, middle panel) . Longer exposures of the TLC plate to X-ray film showed weak activity against the shorter saturated fatty acids. The control infected 19 cells expressing steroid 5 -reductase did not reduce any of the fatty acids tested although all substrates were incorporated into other lipid products by endogenous enzymes (lower panel).
The subcellular localizations of the FAR1 and FAR2 enzymes were determined by immunocytochemistry (Fig. 6) . The mouse cDNAs were engineered to contain FLAG epitopes at the amino termini of the encoded proteins and the resulting modified cDNAs cloned into pCMV expression vectors. The introduction of the FLAG epitope did not affect the fatty acyl-CoA reductase activities of the two modified enzymes when the constructs were expressed in HEK 293 cells (data not shown). Transfection of the DNAs into CHO-K1 cells followed by staining with anti-FLAG monoclonal antibody showed that both the FAR1 (Fig. 6 , middle row, panel E) and FAR2 enzymes (Fig. 6, lower row, panel H) localized to peroxisomes distributed throughout the cytoplasm of expressing cells. The identification of these vesicular bodies as peroxisomes was confirmed by costaining with a polyclonal antiserum directed against a targeting sequence (serine-lysineleucine, SKL) present in many peroxisomal enzymes (15). As seen in Fig. 6 panels A, D, and G, this antiserum recognized the same type of subcellular organelle in all cells on the cover slip, and when these rhodamine images were merged with the fluorescein images generated with the anti-FLAG antibody, many peroxisomes in transfected cells were observed to express both antigens (Fig. 6, panels F, I ). Pair-wise sequence comparisons between the mammalian FAR enzymes and the previously defined plant and insect orthologs reveal approximately 30% amino acid identity (Fig. 1) . Searches with the mouse protein sequences indicate putative fatty acylCoA reductases in many species, including the toad (Xenopus laevis, GI28277293), mosquito (Anopheles gambiae, e.g., GI31197903, and many others), rat (GI34859004), zebra fish (GI28278322), fruit fly (Drosophila melanogaster, e.g., GI24654209 and many others), and nematode (Caenorhabditis elegans, GI17570463). The prospective reductases are 33% (mosquito) to 96% (rat) identical in sequence to the mouse FAR enzymes, with identity extending over the complete length of the compared proteins.
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Homologous sequences include so-called "male sterility proteins" that are implicated in lipid synthesis and the formation of the pollen cell wall in plants (17) , and in the case of wheat, have been shown to have fatty acyl-CoA reductase enzyme activity (8) .
Comparisons between the known and presumed reductases show that only a small number of amino acids are conserved across species. For example, between mouse, plant and insect proteins, only 61 amino acids (~13%) are identical (Fig. 1) . Thirteen of the highly conserved residues are either glycines or prolines, which may play structural roles in these proteins. No obvious NADPH cofactor binding or catalysis sites were found among the conserved sequences.
In mice and humans, the FAR1 and FAR2 isozymes share ~58% sequence identity and are encoded by genes of similar structure, suggesting they arose from a common evolutionary precursor via duplication. This genetic event is presumably ancient as apparent orthologs for each isozyme are present in several species for which complete genome sequences are available, including the puffer fish (Fugu rubripes, FRUP00000132990 and FRUP00000130769) and the rat (XP_215022.2 and NW_047696.1).
The conservation of two isozymes in distantly related species represents one line of evidence that each FAR protein has a different biological function. This idea is further supported by their different fatty acid substrate preferences (Fig. 5) , and their differential expression in tissues (Fig. 2) . FAR1 is broadly distributed and acts on fatty acids that vary in size and saturation, suggesting that this isozyme plays a general role in the synthesis of fatty alcohols. In contrast, the narrow distribution and substrate preference of the FAR2 isozyme are indicative of a more specialized function. Some support for this 22 division of labor is to be found in the ether lipids (plasmalogens) of tissues expressing the FAR1 enzyme, which have diverse structures consistent with the production and incorporation of a variety of fatty alcohols into this class of lipids (10) . Furthermore, the fatty alcohol composition of waxes secreted by the sebaceous glands of mouse skin are different from those of the preputial gland (2), which may reflect the differential expression and substrate specificities of the FAR1 and FAR2 enzymes in these tissues.
In the experiments reported here, the FAR1 enzyme was consistently more active in reducing fatty acids than the FAR2 enzyme when assayed in intact cells (e.g., Fig. 3 ).
The reason for this difference was not ascertained but did not appear to be due to discrepancies in expression level as judged by immunoblotting (data not shown), substrate preference (Fig. 5 ), or differences in subcellular localization (Fig. 6) . The data for a given FAR mRNA were normalized to the threshold values (C T ) determined in the liver (FAR1 mRNA = 27.4, FAR2 mRNA = 28.0) and then expressed on a log 10 scale. This experiment was repeated twice on different days using the same preparations of tissue RNAs, which were isolated from pools of animals (organ samples) or dishes (cell samples). 
